Atlas Trials

Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR

Clinical trial NCT03659058 · COMPLETED

Trial details

NCT number
NCT03659058
Sponsor
Zagazig University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Fibrosis, Liver
Start date
2016-03-02
Primary completion
2018-08-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.